查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1847197

中国牙科移植骨替代物市场：市场规模、份额和趋势分析（2025-2031年）

Dental Bone Graft Substitutes Market Size, Share & Trends Analysis | China | 2025-2031 | Includes: Dental Barrier Membranes, Antimicrobial Periodontal Treatment, and 2 more
出版日期: | 出版商: iData Research Inc. | 英文 81 Pages | 商品交期: 最快1-2个工作天内

价格
如有价格方面的疑问请按下「询问」键来信查询

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年中国牙科移植骨替代物（DBGS）和其他生医材料市场规模约为 2.64 亿美元，预计到 2031 年将达到约 6.9 亿美元，年复合成长率为 14.7%。

本报告涵盖牙科移植骨替代物、牙科屏障膜、局部抗菌牙周治疗、牙科软组织伤口护理。这些类别统称为牙科生医材料市场。本研究量化了销售量、平均售价 (ASP)、市场规模、成长率和企业市场占有率。此外，报告还分析了市场趋势和驱动因素、近期併购活动、技术和实践趋势以及竞争策略。报告提供截至 2021 年的历史数据，并预测至 2031 年。

中国是牙科生医材料市场成长最快的地区之一。推动这一增长的因素包括人工植牙手术数量的增加、消费者对再生牙科认知度的提高以及同种异体和异种移植材料的接受度不断提高。虽然合成材料仍然很重要，但同种异体和异质骨移植领域正在迅速扩张，重塑产品组合和定价模式。

市场概览

随着植入在私人诊所和医院的普及，中国牙科生医材料市场正在快速扩张。中阶的壮大、牙科医疗服务的可及性提高以及对先进修復技术的投入，都推动了对可预测的骨骼和软组织再生材料的需求。

成长最快的生医材料是牙科移植骨替代物。尤其值得注意的是，同种异体移植和异质骨移植材料的市占率成长速度超过了合成材料。这一转变反映了临床对生物移植材料日益增长的信心以及患者接受度的提高。同时，符合各国监管要求的本地供应商的出现，也使得这些材料更易于取得且价格更实惠。

随着临床医生对引导性骨骼和组织再生术的通讯协定进行标准化，屏障膜的应用日益普及。随着训练的普及，越来越多的临床医生将植骨材料与可吸收膜和不可吸收膜结合使用，以改善治疗效果并减少再次植骨手术。抗菌牙周治疗和软组织创伤护理产品透过支持感染控制和促进癒合，完善了整个治疗生态系统。

市场成长仍然对监管流程和定价非常敏感。国家食品药物管理局（CFDA）的要求、诊所预算和私人医疗模式都会影响产品的选择和时机。儘管如此，由于植入使用案例的增加、教育的普及以及同种异体和异质骨移植在日常实践中的应用日益规范化，长期前景仍然光明。

市场驱动因素

人工植牙治疗的发展

大多数骨移植手术都应用于植入病例。随着植入数量的增加，能够从骨移植中获益​​的患者数量也随之增加。虽然并非所有植入都需要骨移植，但许多植牙部位存在需要改善体积或轮廓的骨缺损。植入与骨移植之间的这种联繫，使得骨移植材料的需求持续稳定。

盖氏利希的全球品牌认知度

盖斯特利希是再生材料领域公认的领导者。其卓越的声誉和悠久的临床历史让中国牙医和患者倍感安心。这种信任促使临床医生在需要稳定操作和可预测结果的情况下采用异质骨移植产品。随着时间的推移，人们对盖斯特利希产品系列的熟悉程度不断加深，最终促成了异质骨移植在部分自体牙修復的广泛应用。

消费者对异质骨移植产品的接受度

教育、同侪审查出版物和科学活动正在提高人们对同种异体移植材料的接受度。随着观念的转变，市场正在形成区域性组织库，并建立更清晰的供应管道。这减少了某些适应症对自体骨的依赖，并为更标准化的再生方案铺平了道路。

培训和临床教育

教育促进技术应用。实作课程与学习小组教授临床医师材料选择、植骨几何形状、膜放置等知识。随着从业者经验的积累，他们更有可能将植骨技术纳入植入计画和牙周治疗方案中。培训有助于提高种植成功率和復诊率。

丰富的产品选择和组合套餐

诊所倾向于简化采购流程。供应商若能提供包含植皮、膜、抗菌垫片和创伤护理产品的全套产品组合，可降低订购的复杂性。捆绑式产品也有助于维持临床工作流程的一致性。随着产品组合的扩展，膜及相关产品以及DBGS材料的使用量可望增加。

市场限制

改善口腔卫生

口腔卫生和预防保健的改善将随着时间的推移减少对复杂修復程序的需求，即使老年人口不断增长，这一趋势也可能减缓 DBGS 和膜基程序的增长速度。

成本与公共卫生系统

如果患者没有医疗保险补贴，使用生医材料的大型牙科手术通常需要自费。价格敏感性可能导致治疗延误或选择价格较低的材料。这种影响在主要城市中心以外的地区更为显着。

严格的法规环境

在中国销售的产品须遵守国家食品药品监督管理总局（CFDA）的规定。外国製造商通常需要完成本地临床试验并经过详细的註册流程。这些程序可能会延迟产品上市，并限制特定品类中的品牌数量，导致市场进入成本高且週期漫长。

疾病传播风险

一些从业者对人源和动物源性材料持谨慎态度。有关组织来源和感染疾病的报道，即使与牙科用途无关，也​​会影响临床医生和患者的选择。这种持续的谨慎促使一些牙科诊所转向人工牙或自体牙。

目标市场和数据范围

  • 定量覆盖范围：市场规模、市场占有率、市场预测、成长率、销售量、平均售价。
  • 定性内容：成长趋势、市场限制、竞争分析和主要竞争对手的 SWOT 分析、併购、公司简介、产品系列、颠覆性技术、影响需求的疾病概述。
  • 时段：基准年为 2024 年，预测至 2031 年，历史资料为 2021 年至 2023 年。
  • 资料来源：对行业领导者的直接访谈、政府医生和监管资料、医院和私人诊所资料、进出口记录、iData Research 内部资料库。
  • 方法说明：收入模型以单位数量乘以平均售价 (ASP) 计算。模型检验采用不同医疗机构的手术量、使用率数据和经销商回馈。

医疗机构包括公立医院、私人医院、学术牙科中心和私人牙科诊所。

目标市场及区隔

牙科移植骨替代物（DBGS）

  • 依类型：同种异体移植、异质骨移植、合成移植

牙科屏障膜

  • 按类型：可吸收、不可吸收
  • 依材料分类：同种异体移植、异质骨移植、复合材料。

抗菌牙周治疗

局部抗菌治疗用于减少牙周袋内的细菌负荷并促进癒合。

牙科软组织伤口护理

  • 按类型：塞子、胶带、泡沫

本部分仅进行单元层面的分析。

每个子类别包括市场价值、销售、平均售价、预期成长率和竞争格局（如适用）。

竞争分析

2024年，盖斯特利希在蓬勃发展的异质骨移植市场中占据领先地位。盖斯特利希的全球声誉和临床成功案例赢得了临床医生的信赖。透过在中国设立本地子公司，盖斯特利希有效克服了文化和沟通障碍，提升了服务水平，并提高了品牌知名度。随着异种移植应用的日益普及，盖斯特利希凭藉其本地化布局和持续的培训，将继续保持其市场领先地位。

山西欧斯瑞德在获得国家食品药品监督管理总局（CFDA）批准后，迅速在同种异体移植材料领域占据主导地位。由于监管严格，国内同种异体移植材料供应商数量仍有限。许多国际同种异体移植材料品牌尚未进入中国市场，这进一步巩固了国内核准供应商的竞争优势。凭藉这一供应优势和对产品领域的专注，山西欧斯瑞德在2024年位列生物材料市场（DBGS）和整体生医材料市场第二名。

德士製药 (Dexcel Pharma) 在 2024 年整体排名中位列第三，主要得益于其在局部抗菌牙周治疗领域的领先地位。该公司的 PerioChip® 产品含有 2.5 毫克洛赫西定洛赫西定定，装在一个小型可生物降解的植入物中，专为置入牙周袋而设计。广泛的临床经验和完善的操作规范支持了该产品在包括中国在内的亚太地区的稳定使用。

各个价格分布和材料类型的竞争都异常激烈。国际品牌强调临床传承和培训，而本土企业则强调符合监管要求、在地化支援和成本控制。这种格局既有利于持续成长，也提高了品质系统、实证医学证据和上市后措施的标准。

科技与临床趋势

  • 同种异体移植和异种移植的快速成长：由于人们认为这些移植材料具有良好的生物性能和易于操作，它们正在领先合成材料获得市场份额。
  • GBR 和 GTR 的标准化：临床医生越来越多地将移植物与可吸收或不可吸收膜结合使用，以提高稳定性和形状保持能力。
  • 注重安全性和加工流程：无菌性、来源透明和文件记录是产品选择的核心。清晰的标籤和培训可以减少混淆。
  • 产品组合捆绑销售：供应商正在推广包含移植片、膜和创伤护理用品的整合套件，以简化病例计划和采购。
  • 缩短就诊时间：易于使用且能减少操作时间的产品更容易被采用，尤其是在就诊量大的诊所。
  • 教育和指导：学习小组和现场课程将加速可预测的、分阶段的重建通讯协定在主要城市以外的地区推广。

地区

本期内容主要涉及中国。

为什么要写这份报告？

中国牙科生医材料市场中最大、成长最快的机会在哪里？

同种异体移植和异质骨移植比例的变化将如何影响定价、培训和供应商份额？

牙周病治疗中成长最快的屏障膜和抗菌剂及其原因。

CFDA 的要求和临床试验需求将如何影响市场进入和产品上市时间表？

成长面临的主要风险有哪些？例如，疾病传播和自付费用等方面的担忧？

供应商应如何整合产品组合以改善交叉销售并简化诊所工作流程？

哪些教育和服务模式可以帮助诊所采用可预测的GBR和GTR通讯协定？

商业团队如何规划以因应不同地区在价格敏感度和产品组合上的差异？

iData Research 的《中国牙科骨移植片替代物及其他生医材料市场报告》透过程序模型、定价细节和企业市场占有率分析来回答这些问题。

利用这份报告，可以按类别量化需求，规划产品发布，设定定价和合约目标，并将培训和支援与快速成长的细分市场相匹配。

目录

图表清单

图表列表

调查方法

全球关税的影响

中国牙科移植骨替代物及其他生医材料市场

  • 执行摘要
    • 中国牙科移植骨替代物及其他生医材料市场概览
    • 竞争分析
    • 市场趋势
    • 流程分段
    • 市场区隔
  • 介绍
    • 牙科骨移植替代物
    • 牙科屏障膜
    • 局部抗菌牙周治疗
  • 手术次数
    • 齿槽骨移植手术
  • 单元分析
    • 按手术类型分類的牙科骨移植替代材料销售情况
    • 牙科屏障膜单元（按尺寸）
  • 外汇
  • 市场概览
  • 市场分析与预测
    • 牙科骨移植替代物市场
    • 牙科屏障膜市场
    • 抗菌牙周病治疗市场
    • 牙科软组织创伤护理市场
  • 驾驶员和约束装置
  • 竞争市占率分析
    • 牙科骨移植替代材料市场竞争格局分析
    • 牙科屏障膜市场竞争格局及市场占有率分析
    • 抗菌牙周治疗市场竞争市占率分析

简称

Product Code: iDATA_CNDBGS25_MS

The Chinese dental bone graft substitute (DBGS) and other biomaterials market was valued at nearly $264 million in 2024. It is expected to grow at a compound annual growth rate of 14.7% to reach almost $690 million by 2031.

This report covers dental bone graft substitutes, dental barrier membranes, local antimicrobial periodontal treatments, and dental soft tissue wound care. Together, these categories are referred to as the dental biomaterials market. The study quantifies unit sales, average selling prices (ASPs), market size, growth rates, and company shares. It also analyzes market drivers and limiters, recent mergers and acquisitions, technology and practice trends, and competitive strategies. The report includes historical data to 2021 and forecasts to 2031.

China is one of the fastest growing markets for dental biomaterials. Growth is supported by higher dental implant procedure volumes, rising consumer awareness of regenerative dentistry, and increased acceptance of allograft and xenograft materials. While synthetic materials remain relevant, the allograft and xenograft segments are expanding faster, which is reshaping product mix and pricing dynamics.

Market Overview

The Chinese dental biomaterials market is scaling quickly as implant dentistry becomes more common in private clinics and hospital departments. A growing middle class, wider access to dental care, and investment in advanced restorative procedures are raising the demand for predictable bone and soft tissue regeneration.

The strongest growth within biomaterials is in dental bone graft substitutes. In particular, allograft and xenograft segments are expanding faster than synthetic materials. This change reflects growing clinical confidence in biologic grafts and improved patient acceptance. The shift also aligns with the introduction of local suppliers that meet national regulatory requirements, which helps with availability and pricing.

Barrier membranes are also gaining traction as clinicians standardize guided bone regeneration and guided tissue regeneration protocols. As training expands, more providers are pairing grafts with resorbable and non-resorbable membranes to improve outcomes and reduce reentry procedures. Antimicrobial periodontal treatments and soft tissue wound care products round out the ecosystem by supporting infection control and healing.

Market growth remains sensitive to regulatory processes and pricing. CFDA requirements, clinic budgets, and out-of-pocket payment models influence what products are selected and when. Even so, the long-term outlook is positive due to an increasing number of implant cases, broader education, and the normalization of allograft and xenograft use in everyday practice.

Market Drivers

Growth of Dental Implant Procedures

Most DBGS procedures occur with implant cases. As the number of implants rises, the pool of patients who can benefit from grafting grows as well. Not every implant requires a graft, but many sites have defects that need volume or contour improvement. This link between implant placement and bone grafting supports steady demand for DBGS materials.

Geistlich's Global Brand Recognition

Geistlich is a recognized leader in regenerative materials. Its reputation and long clinical history help reassure dentists and patients in China. This trust encourages adoption of xenograft products in cases where clinicians seek consistent handling and predictable outcomes. Over time, familiarity with Geistlich's portfolio has supported a wider use of xenografts in place of some autogenous options.

Consumer Acceptance of Allograft Products

Acceptance of allograft materials has improved due to education, peer-reviewed publications, and conference activity. As perception shifts, the market has seen the formation of regional tissue banks and a clearer supply pathway. This has reduced reliance on autogenous bone in select indications and opened the door for more standardized regenerative protocols.

Training and Clinical Education

Education drives utilization. Hands-on courses and study clubs teach clinicians how to select materials, shape grafts, and place membranes. As providers gain experience, they are more likely to integrate grafting into implant plans and periodontal treatment paths. Training supports higher success rates and repeat adoption.

Broader Product Choice and Portfolio Bundling

Clinics prefer streamlined purchasing. Suppliers that offer grafts, membranes, antimicrobial inserts, and wound care in one portfolio can reduce ordering complexity. Bundled offerings also support consistent clinical workflows. As portfolios expand, adoption of membranes and related products tends to rise alongside DBGS materials.

Market Limiters

Improvements in Dental Health

Better oral hygiene and preventive care reduce the need for complex restorative work over time. This trend can slow the growth rate of procedures that use DBGS and membranes, even as the older population grows.

Costs and the Public Health System

Major dental procedures that use biomaterials are generally paid out of pocket if patients do not carry supplemental coverage. Price sensitivity can delay treatment or steer choices to lower cost materials. This effect is stronger outside large urban centers.

Strict Regulatory Environment

Products sold in China are subject to CFDA requirements. Foreign manufacturers often need to complete local clinical studies and navigate a detailed registration process. These steps can delay product launches and limit the number of available brands in select categories. As a result, market entry costs are higher and timelines are longer.

Risk of Disease Transmission

Some practitioners remain cautious about human or animal-derived materials. Reports about tissue sourcing or infection can influence clinician and patient choices, even when unrelated to dental use. Persistent caution can shift usage toward synthetic or autogenous options in some clinics.

Market Coverage and Data Scope

  • Quantitative coverage: Market size, market shares, market forecasts, growth rates, units sold, and ASPs.
  • Qualitative coverage: Growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles, product portfolios, disruptive technologies, and disease overviews that shape demand.
  • Time frame: Base year 2024, forecasts to 2031, historical data from 2021 to 2023.
  • Data sources: Primary interviews with industry leaders, government physician and regulatory data, hospital and private clinic data, import and export records, and the iData Research internal database.
  • Method note: Revenue is modeled as units multiplied by ASP. Models are validated with procedure volumes, utilization inputs, and distributor feedback across care settings.

Care settings include public hospitals, private hospitals, academic dental centers, and private dental clinics.

Markets Covered and Segmentation

Dental Bone Graft Substitutes (DBGS)

  • By type: Allografts, xenografts, synthetics.

Dental Barrier Membranes

  • By type: Resorbable, non-resorbable.
  • By material: Allografts, xenografts, synthetics.

Antimicrobial Periodontal Treatment

Local antimicrobial therapies used to reduce bacterial load and support healing in periodontal pockets.

Dental Soft Tissue Wound Care

  • By type: Plug, tape, foam.

This segment is analyzed at a unit level only.

Each subcategory includes market values, unit volumes, ASPs, and forecast growth, along with competitive context where applicable.

Competitive Analysis

Geistlich led the expanding xenograft market in 2024. The company's global reputation and documented clinical track record support strong clinician trust. By establishing a local affiliate in China, Geistlich addressed cultural and communication barriers, enhanced service levels, and increased brand awareness. This local presence, combined with ongoing education, positions Geistlich to keep its leadership as xenograft usage grows.

Shanxi OsteoRad held a leading position in the allograft category after gaining CFDA approval for its products. Due to strict regulation, the number of allograft suppliers in China remains limited. Many international allograft brands have not yet entered the market, which strengthens the competitive stance of approved domestic providers. Shanxi OsteoRad ranked second in the overall DBGS and biomaterials market in 2024 due to this supply position and category focus.

Dexcel Pharma ranked third overall in 2024, supported by leadership in local antimicrobial periodontal treatment. Its PerioChip(R) product contains 2.5 mg chlorhexidine digluconate in a small biodegradable insert designed for placement into periodontal pockets. Broad clinical familiarity with chlorhexidine and established handling protocols support stable usage across Asia Pacific, including China.

Competition is active across price tiers and material types. International brands emphasize clinical heritage and training, while domestic firms focus on regulatory alignment, localized support, and cost control. This structure supports continued growth but also raises the bar for quality systems, evidence, and post-market engagement.

Technology and Practice Trends

  • Faster growth in allograft and xenograft: These categories are gaining share ahead of synthetics due to perceived biological performance and handling.
  • Standardization of GBR and GTR: More clinicians pair grafts with resorbable or non-resorbable membranes to improve stability and shape maintenance.
  • Focus on safety and processing: Sterilization, sourcing transparency, and documentation are central to product selection. Clear labeling and training reduce hesitation.
  • Portfolio bundling: Suppliers promote integrated kits that include grafts, membranes, and wound care items to streamline case planning and purchasing.
  • Chair-time efficiency: Products that handle well and reduce surgical time support adoption, especially in high-volume clinics.
  • Education and mentorship: Study clubs and live courses accelerate the spread of predictable, stepwise regenerative protocols beyond major cities.

Geography

This edition covers China.

Why This Report

Where are the largest and fastest-growing opportunities within China's dental biomaterials market.

How will the mix shift toward allograft and xenograft affect pricing, training, and supplier share.

Which barrier membranes and periodontal antimicrobials are expanding most quickly and why.

How do CFDA requirements and clinical study needs affect market entry and product timelines.

What are the key risks to growth, including disease transmission concerns and out-of-pocket costs.

How should suppliers bundle portfolios to improve cross-selling and simplify clinic workflows.

What education and service models help clinics adopt predictable GBR and GTR protocols.

How can commercial teams plan for regional differences in price sensitivity and product mix.

The China Dental Bone Graft Substitute and Other Biomaterials Market Report from iData Research answers these questions with procedure-aware models, pricing detail, and company share analysis.

Use it to quantify demand by category, plan product launches, set pricing and contracting targets, and align training and support with the fastest growing segments.

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

Research Methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems And Perform Secondary Research
  • Step 3: Preparation For Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast And Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review And Market Release
  • Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

China Dental Bone Graft Substitute and Other Biomaterials Market

  • 8.1 Executive Summary
    • 8.1.1 China Dental Bone Graft Substitute and Other Biomaterials Market Overview
    • 8.1.2 Competitive Analysis
    • 8.1.3 Market Trends
    • 8.1.4 Procedure Segmentation
    • 8.1.5 Market Segmentation
  • 8.2 Introduction
    • 8.2.1 Dental Bone Graft Substitutes
      • 8.2.1.1 Autografts
      • 8.2.1.2 Allografts
      • 8.2.1.2.1 Mineralized Allografts
      • 8.2.1.2.2 Demineralized Bone Matrix
      • 8.2.1.3 Xenografts
      • 8.2.1.4 Synthetics
    • 8.2.2 Dental Barrier Membranes
    • 8.2.3 Local Antimicrobial Periodontal Treatment
  • 8.3 Procedure Numbers
    • 8.3.1 Dental Bone Grafting Procedures
  • 8.4 Unit Analysis
    • 8.4.1 Dental Bone Graft Substitute Units Sold by Procedure Type
    • 8.4.2 Dental Barrier Membrane Units Sold by Size
      • 8.4.2.1 Resorbable Dental Barrier Membrane Units Sold by Size
      • 8.4.2.2 Non-Resorbable Dental Barrier Membrane Units Sold by Size
  • 8.5 Currency Exchange Rate
  • 8.6 Market Overview
  • 8.7 Market Analysis and Forecast
    • 8.7.1 Dental Bone Graft Substitute Market
      • 8.7.1.1 Allograft Market
      • 8.7.1.2 Xenograft Market
      • 8.7.1.3 Synthetic Market
    • 8.7.2 Dental Barrier Membrane Market
      • 8.7.2.1 Dental Barrier Membrane Market by Segment
      • 8.7.2.1.1 Allograft Dental Barrier Membrane Market
      • 8.7.2.1.2 Xenograft Dental Barrier Membrane Market
      • 8.7.2.1.3 Synthetic Dental Barrier Membrane Market
      • 8.7.2.2 Dental Barrier Membrane Market by Material
      • 8.7.2.2.1 Resorbable Dental Barrier Membrane Market
      • 8.7.2.2.2 Non-Resorbable Dental Barrier Membrane Market
    • 8.7.3 Antimicrobial Periodontal Treatment Market
    • 8.7.4 Dental Soft Tissue Wound Care Market
      • 8.7.4.1 Dental Wound Care Plugs Market
      • 8.7.4.2 Dental Wound Care Tape Market
      • 8.7.4.3 Dental Wound Care Foam Market
  • 8.8 Drivers and Limiters
    • 8.8.1 Market Drivers
    • 8.8.2 Market Limiters
  • 8.9 Competitive Market Share Analysis
    • 8.9.1 Dental Bone Graft Substitute Market Competitive Market Share Analysis
    • 8.9.2 Dental Barrier Membrane Market Competitive Market Share Analysis
    • 8.9.3 Antimicrobial Periodontal Treatment Market Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

  • Chart 8-1: Dental Bone Graft Substitute and Other Biomaterials by Segment, China, 2024
  • Chart 8-2: Dental Bone Graft Substitute and Other Biomaterials Market Overview, China, 2024 & 2031
  • Chart 8-3: Dental Bone Grafting Procedures by Segment, China, 2021 - 2031
  • Chart 8-4: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, China, 2021 - 2031
  • Chart 8-5: Leading Competitors, Dental Bone Graft Substitute and Other Biomaterials Market, China, 2024

LIST OF FIGURES

  • Figure 8-1: Dental Bone Graft Substitute and Other Biomaterials Market Share Ranking by Segment, China, 2024
  • Figure 8-2: Factors Impacting the Dental Bone Graft Substitute and Other Biomaterials Market by Segment, China
  • Figure 8-3: Dental Bone Graft Substitute and Other Biomaterials Procedure Segmentation, China
  • Figure 8-4: Dental Bone Graft Substitute and Other Biomaterials Market Segmentation, China
  • Figure 8-5: Dental Bone Grafting Procedures and Penetration Rates by Segment, China, 2021 - 2031
  • Figure 8-6: Dental Bone Graft Procedure Numbers and Volume Usage by Application, China, 2021 - 2031 (1 of 2)
  • Figure 8-7: Dental Bone Graft Procedure Numbers and Volume Usage by Application, China, 2021 - 2031 (2 of 2)
  • Figure 8-8: Dental Bone Graft Units Sold by Procedure, China, 2021 - 2031
  • Figure 8-9: Resorbable Dental Barrier Membrane Units Sold by Size, China, 2021 - 2031
  • Figure 8-10: Non-Resorbable Dental Barrier Membrane Units Sold by Size, China, 2021 - 2031
  • Figure 8-11: Currency Exchange Rate, 2024
  • Figure 8-12: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, China, 2021 - 2031 (US$M)
  • Figure 8-13: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, China, 2021 - 2031 (CH¥M)
  • Figure 8-14: Total Dental Bone Graft Substitute Market, China, 2021 - 2031
  • Figure 8-15: Dental Bone Graft Substitute Market by Segment, China, 2021 - 2031 (US$M)
  • Figure 8-16: Dental Bone Graft Substitute Market by Segment, China, 2021 - 2031 (CH¥M)
  • Figure 8-17: Allograft Market, China, 2021 - 2031
  • Figure 8-18: Xenograft Market, China, 2021 - 2031
  • Figure 8-19: Synthetic Market, China, 2021 - 2031
  • Figure 8-20: Total Dental Barrier Membrane Market, China, 2021 - 2031
  • Figure 8-21: Dental Barrier Membrane Market by Segment, China, 2021 - 2031 (US$M)
  • Figure 8-22: Dental Barrier Membrane Market by Segment, China, 2021 - 2031 (CH¥M)
  • Figure 8-23: Allograft Dental Barrier Membrane Market, China, 2021 - 2031
  • Figure 8-24: Xenograft Dental Barrier Membrane Market, China, 2021 - 2031
  • Figure 8-25: Bovine Xenograft Dental Barrier Membrane Market, China, 2021 - 2031
  • Figure 8-26: Porcine Xenograft Dental Barrier Membrane Market, China, 2021 - 2031
  • Figure 8-27: Synthetic Dental Barrier Membrane Market, China, 2021 - 2031
  • Figure 8-28: Dental Barrier Membrane Market by Material, China, 2021 - 2031 (US$M)
  • Figure 8-29: Dental Barrier Membrane Market by Material, China, 2021 - 2031 (CH¥M)
  • Figure 8-30: Resorbable Dental Barrier Membrane Market, China, 2021 - 2031
  • Figure 8-31: Non-Resorbable Dental Barrier Membrane Market, China, 2021 - 2031
  • Figure 8-32: Non-Reinforced Non-Resorbable Dental Barrier Membrane Market, China, 2021 - 2031
  • Figure 8-33: Titanium-Reinforced Non-Resorbable Dental Barrier Membrane Market, China, 2021 - 2031
  • Figure 8-34: Total Antimicrobial Periodontal Treatment Market, China, 2021 - 2031
  • Figure 8-35: Dental Wound Care Market by Type, China, 2021 - 2031 (US$M)
  • Figure 8-36: Dental Wound Care Market by Type, China, 2021 - 2031 (CH¥M)
  • Figure 8-37: Dental Soft Tissue Wound Care Market, China, 2021 - 2031
  • Figure 8-38: Dental Wound Care Plugs Market, China, 2021 - 2031
  • Figure 8-39: Dental Wound Care Tape Market, China, 2021 - 2031
  • Figure 8-40: Dental Wound Care Foam Market, China, 2021 - 2031
  • Figure 8-41: Leading Competitors, Dental Bone Graft Substitute and Other Biomaterials Market, China, 2024
  • Figure 8-42: Leading Competitors, Dental Bone Graft Substitute Market, China, 2024
  • Figure 8-43: Leading Competitors, Dental Barrier Membrane Market, China, 2024
  • Figure 8-44: Leading Competitors, Antimicrobial Periodontal Treatment Market, China, 2024